Tranquility Biodesign LLC
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $354,996 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase I therapeutic award: a novel engineered bacterial anticancer immunotherapy for merkel cell carcinoma | National Cancer Institute (NIH) | $354,996 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Missouri System | AY1AX000010 | $342,355 |
Quick answers
Is Tranquility Biodesign LLC registered in SAM.gov?
Tranquility Biodesign LLC's SAM.gov registration expired on November 7, 2026.
What is Tranquility Biodesign LLC's CAGE code?
Tranquility Biodesign LLC's CAGE code is 9MP38, and its Unique Entity ID (UEI) is RZ6PUGHFTM97.
How much has Tranquility Biodesign LLC received in federal contracts?
Federal contracts obligated $354,996 to Tranquility Biodesign LLC in fiscal years 2023 through 2027.
What is Tranquility Biodesign LLC's most recent federal award?
Tranquility Biodesign LLC's most recent federal contract award is Phase I therapeutic award: a novel engineered bacterial anticancer immunotherapy for merkel cell carcinoma (75N91024C00006), from National Cancer Institute (NIH), on February 21, 2024.
On GovTribe
See Tranquility Biodesign LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors